iPS Cells & Regenerative Medicine Weekly Report May 24, 2026

iPS Cells & Regenerative Medicine Weekly Report September 20, 2026

Ori Biotech Secures $120M, 10-Year Partnership for Automated Cell Therapy Manufacturing; Vyriad’s In Vivo CAR-T Clears IND

Vertex Pharmaceuticals Initiates Phase I/II for Type 1 Diabetes Cell Therapy, Expands Renal Pipeline at Morgan Stanley Conference

Tempest Therapeutics Licenses Senlang’s In Vivo CAR-T Platform, Targeting Relapsed/Refractory Multiple Myeloma with Dual BCMA/GPRC5D Approach in Phase I Trial

Indian Health Ministry Issues Advisory to States, UTs to Regulate Stem Cell Therapy; Limits Autism Application to Clinical Trials

UA Little Rock Secures Grant to Develop 3D Tissue Scaffold Replicating Human Intestinal Villi-Crypt Structures

BioInformant Report Outlines 2026 iPSC-Derived Cell Therapeutic Pipeline, Highlighting Safety Challenges and Key Developers

GC Cell’s CAR-NK Therapy GCC2005 Approved for Compassionate Use in Refractory T-Cell Lymphoma at SNUH, South Korea